Harshit_Saxena

Intraday study for Indian indices for 22 November 2022

Long
Harshit_Saxena Updated   
NSE:NIFTY   Nifty 50 Index
Hi Good Moring

yesterday the nifty witness the sell off sponsor by the CNXIT and Reliance along with the major stocks remains sideways with negative bias around 1% but we saw that the banks looks good and bank nifty holds the level and give support to the indices for further down move all this because the FED meeting minutes yet to come which is at 23 November in the global market there is a consolidation and the Nasdaq holds the level of 11000 and Dow's holds the level of 33500 and also all this happens because of the covid and restrictions from China. Now we talk about the Indian markets and stocks todays level

Nifty:---

Nifty looks good as it holds the support of 18050-18150 range given by me and it holds the upper band of the range yesterday and the SGXNIFTY is indicating the gapup the resistance is t 18250-18275-18325 range and support is as indicated

banknifty:---

the support is in the range of 41800-42200 rang and the 42200 is it self a strong support with the resistance of 42500-42800

the sector and the stocks is

PSUBANKS, FERTILIZERS, CAPITALGOODS , PHARMA, PVTBANKS, PSU, TELECOM, REALTY, CNXIT ALSO if recovery comes the huge upmove is given by IT stocks and banks on top

Disclaimer -- I may have some positions in some of highlighted stocks and this is only study for understanding purposed of the data and the patterns I am not saying anyone to buy any of these picks discussed here i am not SEBI Registered

Comment:
any who wants to looks for along trade apart from banks then CNXIT looks good if it gives 30 min candle closure above 29270
Comment:
Data is positive in NIFTY one can go long in this at given levels
Comment:
hope you are watching CNXIT 100 points ip from highlighted levels and closure to 29270
Comment:
now see INFY and HCLTECH and other major it move
Comment:
hope you all capture and enjoying

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.